Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis

BACKGROUND: Cholangiocarcinoma (CCA) is a malignant tumor originating from bile duct epithelial cells that no obvious clinical symptoms and specific clinical manifestations are shown in the early stage of CCA. METHODS: Propensity score matching (PSM) is a quasi-experimental method in which this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qing, Chang, Zhenyu, Wang, Tianyi, Liu, Bing, Wang, Ximin, Ge, Xin-Yu, Yang, Tao, Liu, Qu, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728389/
https://www.ncbi.nlm.nih.gov/pubmed/36505810
http://dx.doi.org/10.3389/fonc.2022.989080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728389/
https://www.ncbi.nlm.nih.gov/pubmed/36505810
http://dx.doi.org/10.3389/fonc.2022.989080

Ejemplares similares